Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 26 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

19%

5 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (6)
P 1 (2)
P 2 (3)
P 3 (4)
P 4 (1)

Trial Status

Completed13
Unknown6
Not Yet Recruiting3
Active Not Recruiting2
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT06786429Phase 4Not Yet Recruiting

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT05742711Not ApplicableCompleted

Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients

NCT05179824Active Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT05709730Active Not RecruitingPrimary

Follow-up of Cell Changes in the Cervix

NCT03133286Completed

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

NCT05990270Not ApplicableCompletedPrimary

The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief

NCT02865135Phase 1Completed

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

NCT06147960UnknownPrimary

Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer

NCT05824494Phase 2Not Yet Recruiting

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

NCT04999696Not ApplicableNot Yet RecruitingPrimary

Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical Cancer

NCT05149248Phase 2CompletedPrimary

Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study

NCT04809727Not ApplicableCompleted

Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

NCT03896958Unknown

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

NCT00193739Phase 3UnknownPrimary

Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix

NCT00193791Not ApplicableCompletedPrimary

Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix

NCT00193804CompletedPrimary

A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix

NCT04022148UnknownPrimary

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

NCT03653819Not ApplicableCompleted

High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs

NCT00193752CompletedPrimary

Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix

Scroll to load more

Research Network

Activity Timeline